Lorenzo Tomassoni

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Urszula N. Wasko, Jingjing Jiang, Tanner C. Dalton et al. · Nature · 2024 · 175 citations · Full text

Medicine, Oncology, Pharmacology +17

Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia

Leonardo Flenghi, M Fagioli, Lorenzo Tomassoni et al. · Blood · 1995 · 105 citations

Life Sciences, Immunology, Molecular Biology +6

Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators

Aleksandar Obradović, Casey R. Ager, Mikko Turunen et al. · Cancer Cell · 2023 · 57 citations · Full text

Life Sciences, Immunology, Pharmacology +14

Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression

Marie C. Hasselluhn, Amanda R. Decker-Farrell, Lukas Vlahos et al. · Cancer Discovery · 2023 · 21 citations · Full text

Medicine, Cancer Biology, Oncology +13

Developmental and MAPK-responsive transcription factors drive distinct malignant subtypes and genetic dependencies in pancreatic cancer

Pasquale Laise, Mikko Turunen, Alvaro Curiel Garcia et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 20 citations · Full text

Medicine, Cell Biology, Oncology +17